Surrozen, Inc. (SRZN) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $11.39 - $37.83

5.7 Year SRZN Performance Metrics:

Total Return (with DRIP): -78.8% (-23.81% CAGR)

Total Return (no DRIP): -78.8% (-23.81% CAGR)

Share Price: -78.8% (-23.81% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $2,122

Total Return $ (with DRIP): -$7,878

SRZN Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

SRZN Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for SRZN

Based on past 5.7-year performance, here are SRZN growth metrics:

Share price CAGR of -23.81%
Dividend CAGR of +0%

Using SRZN CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	SRZN (DRIP)	SRZN - No DRIP
Current Price	$32.18	$32.18
Start Shares	310.75	310.75
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	310.75	310.75
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$2.12	$32.18
Total Dividends	$0	$0
Final Value	$659	$10,000

Estimated Future Value + Dividends - SRZN

NOTE: Above numbers are our estimate based on SRZN's Dividend and Price CAGR over past 5.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Surrozen, Inc. (SRZN) had its IPO on , and is traded on NASDAQ stock exchange.

Surrozen, Inc. is a biotechnology company focused on developing antibody-based therapeutics that selectively modulate the Wnt pathway to support tissue repair and regeneration. The company’s current programs are centered on ophthalmology, with candidates aimed at retinal diseases, diabetic macular edema, wet age-related macular degeneration, uveitic macular edema, Fuchs’ endothelial corneal dystrophy, and geographic atrophy. Surrozen also works on tissue-specific biologics designed to engage the body’s natural repair mechanisms in other disease areas, including the intestine, liver, lung, kidney, skin, pancreas, and central nervous system. Based in South San Francisco, California, Surrozen’s role in the market is that of a clinical-stage drug developer pursuing precision biologics for serious conditions with high unmet medical need.

SRZN website: https://www.surrozen.com